相关实验视频

Updated: Jan 17, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

针对非肌肉侵入性膀癌的向治疗 - 临床更新

Rachel Passarelli¹, John Pfail¹, David Golombos²

¹Division of Urology, Rutgers Robert Wood Johnson University Hospital, New Brunswick, NJ 08901, USA.

Archives of pharmacology and therapeutics

|September 18, 2025

概括

非肌肉侵入性膀癌 (NMIBC) 的复发率很高. 针对基因突变的精准医学为NMIBC患者提供了有前途的新型膀节省疗法,目前正在进行临床试验.

科学领域:

在瘤学瘤学.
泌尿器科泌尿器科泌尿器科泌尿器科
遗传学是一个遗传学.

背景情况:

非肌肉侵入性膀癌 (NMIBC) 占膀癌诊断的75% .
目前的化疗和Bacillus Calmette-Guerin (BCG) 等治疗方法在高风险患者中复发率很高 (40-50%).
虽然推用于高风险NMIBC的激进囊切除术,但涉及高发病率,不适合所有患者.

研究的目的:

审查NMIBC针对性治疗的最新进展.
评估NMIBC中准确医学的初步结果和正在进行的临床试验.
预测NMIBC不断变化的治疗环境.

主要方法:

进行了PubMed和Medline (OVID) 的文献审查,以研究NMIBC向疗法的研究.
在clinicaltrials.gov上进行了对NMIBC临床试验的搜索.
针对针对性NMIBC治疗的综合初步结果和试验数据.

主要成果:

初步数据表明,在NMIBC中针对性治疗的结果是有希望的.
许多临床试验正在研究有针对性的治疗方法,许多是在后期阶段.
了解NMIBC分子特征的进步正在推动精准医学方法的发展.

结论:

向疗法是NMIBC日益增长的研究领域.
精准医学有潜力为更有效的,节省膀的NMIBC治疗.
预计即将到来的研究和试验将对NMIBC治疗模式产生重大影响.

关键词:

膀癌是一种癌症.非肌肉侵入性膀癌是什么?精准医学是一门精准的医学.目标疗法目标疗法

更多相关视频

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment

An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment

Published on: July 28, 2012

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.